Patient access schemes (PAS) are innovative pricing agreements, proposed by pharmaceutical companies, designed to improve cost effectiveness and facilitate patient access to specific drugs or other technologies. The table below shows treatments recommended by NICE through NICE technology appraisals, alongside their approved PAS and other commercial arrangements, for use in the NHS.
Please sign in to continue reading this content, or...
Register for free
Access to the Specialised Medicine website is free for UK healthcare professionals and NHS managers with a role or interest in specialised healthcare and commissioning.
Sign up now–it takes less than a minute and you’ll get unlimited access to all of our independent content, including expert articles, news, views, and specialised service resources.